Recurrence Reduction
Recurrence Reduction is a clinical outcome metric in oncology that quantifies the extent to which adjuvant chemotherapy decreases the incidence of cancer relapse following primary treatment.
231
Publications
19.4K
Citations
2.2K
Authors
709
Institutions
Publications per year
2017–2026
64
Parents
231
Effective Surgical Adjuvant Therapy for High-Risk Rectal Carcinoma
James E. Krook, C G Moertel, Leonard L. Gunderson et al. · New England Journal of Medicine · 1991 · 1.9K citations
Thierry Conroy, Jean-François Bosset, Pierre-Luc Etienne et al. · The Lancet Oncology · 2021 · 1.3K citations
Maxime J.M. van der Valk, Denise E. Hilling, Esther Bastiaannet et al. · The Lancet · 2018 · 1.1K citations · Full text
1–5 of 231
2.2K
6
h-index
Leiden University Medical Center, Netherlands
5 publications · 1.3K citations
5
h-index
Leiden University Medical Center, Netherlands
4 publications · 1.2K citations
4
h-index
4
h-index
4
h-index
1–5 of 2.2K
709
The University of Texas MD Anderson Cancer Center
Houston, United States
9 h-index
48 publications
2K citations

Radboud University Nijmegen
Nijmegen, The Netherlands
6 h-index
30 publications
1.6K citations
Harvard University
Cambridge, United States
6 h-index
14 publications
528 citations
Memorial Sloan Kettering Cancer Center
New York, United States
6 h-index
32 publications
789 citations
Massachusetts General Hospital
Boston, United States
5 h-index
9 publications
511 citations

University of Padua
Padua, Italy
5 h-index
10 publications
625 citations

Leiden University Medical Center
Leiden, The Netherlands
5 h-index
25 publications
8.2K citations

Princess Margaret Cancer Centre
Toronto, Canada
5 h-index
8 publications
569 citations
1–8 of 709
19 publications · 3K citations
16
h-index
Repository · 17 publications · 564 citations
13
h-index
9 publications · 478 citations
9
h-index
9 publications · 938 citations
9
h-index
BJS · 6 publications · 396 citations
6
h-index
1–5